APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.

http://www.wikidata.org/entity/Q30823419

about

Resting-State Functional Connectivity in Individuals with Down Syndrome and Williams Syndrome Compared with Typically Developing Controls Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?Apolipoprotein E Gene Variants and Risk of Coronary Heart Disease: A Meta-Analysis APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention Association of Alzheimer's disease GWAS loci with MRI markers of brain aging Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.DIAGNOSIS-GUIDED METHOD FOR IDENTIFYING MULTI-MODALITY NEUROIMAGING BIOMARKERS ASSOCIATED WITH GENETIC RISK FACTORS IN ALZHEIMER'S DISEASE.Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers.Interaction between C-reactive protein and cognitive functions according to APOE gene polymorphism in post-menopausal women.Physical Activity: A Viable Way to Reduce the Risks of Mild Cognitive Impairment, Alzheimer's Disease, and Vascular Dementia in Older Adults.Genetics and brain morphology.The Electrophysiological Phenomenon of Alzheimer's Disease: A Psychopathology Theory.Benefits and risks of add-on therapies for Alzheimer's disease.Dementia risk and prevention by targeting modifiable vascular risk factors.Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review.APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.State of Play in Alzheimer's Disease Genetics.Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.Risk and protective factors for structural brain ageing in the eighth decade of life.Risk Factors Associated With Early vs Delayed Dementia After Intracerebral Hemorrhage.Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden.Modulation of glucose metabolism and metabolic connectivity by β-amyloid.A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.Differential 5-year brain atrophy rates in cognitively declining and stable APOE-ε4 elders Treatment with Growth Hormone (GH) Increased the Metabolic Activity of the Brain in an Elder Patient, Not GH-Deficient, Who Suffered Mild Cognitive Alterations and Had an ApoE 4/3 Genotype

P2860

Q27307963-AC2BF8FB-40A6-44D1-B37C-3238FDB3D107 Q28069073-CB2B4B09-917B-429A-B2BE-7F9D894F744A Q28073311-9A6EC0FC-3CBA-4667-8142-26B542FD3C35 Q33563660-42FC16EB-9FB2-4AC4-A661-DFA75E2090CF Q33838291-99F03531-6705-4611-99AC-17E3D68ECDFE Q35339698-5C1E7FE2-8E1D-4C76-B810-315EBE1F4275 Q35989824-DEE13B1C-3419-4B50-B5C0-18263CC0E3F5 Q36266994-BD8E39C5-4307-48A5-9696-AB07F027AF1E Q36413581-09325619-0379-45EB-B301-608E0D958691 Q36481870-B2BC3785-66BE-4401-A8CC-19870A64BABD Q36510006-C8D75F0C-AA6F-428D-B7C4-816FEA6D1651 Q36692478-F56DBDE4-512B-4A4D-902C-2597FE6F168F Q37412664-058B30AA-30BA-4A68-BB77-4FD8307730B9 Q37676108-61ACEAAD-9721-4078-845C-CFD55B772AF4 Q38379199-32AADD34-EE2C-430D-9435-F3460CF18C17 Q38588411-413A26BE-A3C8-4155-9A96-74E649437B50 Q38620338-32FC2B29-073F-42C9-8853-D95BC3A4D30C Q38653373-1A5FF7F0-CBCE-44D5-A49A-4102B7738609 Q38669324-F5BBDB45-33B4-4CC8-8E0C-EBB928908589 Q38784011-138D163C-46CB-45BA-954E-EFC78635D751 Q38944065-9A9E9E55-F6FB-4382-8292-F1593AF2B6C5 Q39307376-B64D98E7-306B-4C99-BDD3-612B752705E4 Q39810517-EF323BF8-D222-484E-A0D3-3FE7D3969FA2 Q40188198-16689A2C-5C1F-4667-BEEF-73934EC0871C Q40235362-AD009FAC-5F40-4202-B79A-977A61322975 Q40704516-26F7E6B8-4454-4740-BF42-8318D77C8253 Q41654576-C199BAE5-6605-4516-85C3-70FC4B8A22E3 Q42174144-20A3169C-6F55-46D7-B5DC-9AE7239276B4 Q44559358-1A80A725-499F-40AD-A2E8-C1A53A125CC4 Q46082316-E953A013-6EEA-4CF1-BEBE-46AB149F9EA4 Q47549663-7BE7043D-4014-47AB-A1C0-E89DFE4041AE Q51703164-228A0877-874B-4304-AC58-B05DEE72508E Q55716341-B6CC1B0D-876C-413C-9A6F-9A9871A2C0E6 Q57165595-D9584606-5218-4B5A-B955-52A42613D88C Q58800000-4767053E-22C2-451A-AAB8-36AD1F99A70C

P2860

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.

http://www.wikidata.org/entity/Q30823419

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@ast

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@en

type

label

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@ast

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@en

prefLabel

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@ast

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@en

P1433

Q30823419-4751E1E0-CFA2-402E-9710-7DD60B32F340

P1476

Q30823419-C40DF1D5-6B97-4668-8183-1452281E1481

P2093

Q30823419-04253ED0-E08A-4070-A08C-457E5DB13D83

Q30823419-38A47EAF-13CF-4709-9ECB-74886C13C7C8

Q30823419-63CC60DC-7632-41DC-B58E-C523EFFDB50A

Q30823419-6E7C2E8D-D53E-4DB8-B398-680A86AA1C99

Q30823419-92C709E5-B68C-4F1B-A8EC-5E34EA156B38

Q30823419-AA9D24C0-7816-42A7-80B9-3C235569F2EF

P2860

Q30823419-097E34F6-D17B-4DCA-AE71-52690B36C577

Q30823419-11067FB6-7673-4583-9983-0DB5A77CACED

Q30823419-11EC6726-6857-4C48-9B3E-E6DDB043CCEF

Q30823419-15BAC101-6373-4ADC-A03B-4DE6B3B535B1

Q30823419-1DCD11DD-0DD8-483F-BA4C-82843D137B5A

Q30823419-28B8549D-A9E2-438E-A3C1-3808A0F0935C

Q30823419-36A82A35-3121-423C-BECB-1A74DDE2C6A8

Q30823419-3907D19C-8255-4EA7-AC46-3C53286CBDEF

Q30823419-464E4460-8A82-4773-A645-906143EB90C9

Q30823419-52560ECD-71E4-419E-9653-4DC490926318

P304

Q30823419-0F787E74-477E-4F14-BAF3-599AFA41EDB7

P31

Q30823419-16BA02FF-32E6-486D-9161-5A12F96361B4

Q30823419-AA591B3B-A079-4221-8987-E5EF8F534942

Q30823419-BC7B0972-BBFC-4A50-B061-A34BC307A7A1

P356

Q30823419-587849DC-10D0-4BF6-BB14-EFC21A1C8B05

P407

Q30823419-1EBAA046-61A5-4FB5-A27B-C1C72703E924

P433

Q30823419-7F5AB538-5E0E-4440-9230-2304BA1520B1

P478

Q30823419-A56F06AF-A929-43A5-814D-DC9516242A2B

P50

Q30823419-8C2CA110-8A58-4FC6-BE30-F6DC30A6F37D

Q30823419-985E9741-C94F-47D1-A127-B885B59A434A

Q30823419-BBE15D02-F03C-431D-BF6A-D0589CC07291

Q30823419-E02F8CAB-8AD4-41B8-AB4A-6700A7D592BA

P577

Q30823419-13BBF7E3-53B0-4239-82E5-D6248F7895A0

P5875

Q30823419-60423B27-5E56-49D5-A56E-8E49AACD2B76

P698

Q30823419-1F183BC5-7E17-4692-A447-91727FB6F993

P921

Q30823419-A672968E-DA04-4E11-89FF-AEF0268FF0E1

Q30823419-C6C78E3E-E9F8-465B-A6C5-DE9F033BA789

P932

Q30823419-D1D2BFDA-6ECF-404F-8986-C4B3AAB1BD0F

P356

JNNP-2014-307719

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

APOE genotype and neuroimaging ...... atic review and meta-analysis.

@en

P2093

Chen-Chen Tan

http://www.w3.org/2001/XMLSchema#string

Chong Wang

http://www.w3.org/2001/XMLSchema#string

Hui-Fu Wang

http://www.w3.org/2001/XMLSchema#string

Pei-Ran Han

http://www.w3.org/2001/XMLSchema#string

Xiang-Fei Meng

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD)

APOE genotype effects on Alzheimer's disease onset and epidemiology

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele

Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

P304

127-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1136/JNNP-2014-307719

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J. Saykin

Shannon L. Risacher

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262421905

http://www.w3.org/2001/XMLSchema#string

P698

24838911

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4331076

http://www.w3.org/2001/XMLSchema#string